Credence MedSystems Wins Drug Delivery Innovation Award

The Companion Received the Award for Best and Most Innovative Advancements in Drug Delivery at Drug Delivery Partnerships Annual Meeting

Loading media player...

The Credence Companion Safety Syringe System

MENLO PARK, Calif.--()--Credence MedSystems, Inc. announced today that the Credence Companion Safety Syringe System has received a major industry honor at last week’s Drug Delivery Partnership Annual Conference in Boca Raton. The Companion won the Drug Delivery Innovation Award for Best and Most Innovative Advancements in Drug Delivery from the past year in the category of Technology Innovation.

The Companion was named for the award by conference attendees, composed of pharmaceutical executives, industry partners and key opinion leaders in the world of drug delivery.

“This is a very important milestone for the Company,” stated Jeff Shanley, Credence’s CEO. “When industry peers recognize your work, it is especially gratifying. Along with the traction we are seeing with pharmaceutical manufacturers, this honor further validates our Innovation Without Change approach.”

The Credence Companion Safety Syringe System originated from Credence’s core philosophy of Innovation Without Change. Because the Companion builds around the foundation of any existing pre-filled syringe and components to provide a best-in-class injection device, pharmaceutical manufacturers can launch their drugs in a differentiated delivery device with a vastly simplified commercialization path and greatly reduced risk profile. The Companion has disrupted the paradigm for launching drugs in advanced delivery systems.

The Companion Syringe offers integrated, passive needlestick prevention for any length needle. At the end of the injection, the user is provided end-of-dose cues and then the needle automatically retracts into the barrel of the syringe, thereby permanently disabling the syringe. The Companion is flexible to the specific needs of the application. It is available with a pre-attached ‘staked’ needle or a luer connection needle and because adhesive is not present in the system, the significant risk of unwanted interaction between the drug substance and adhesive is removed.

Credence will again be exhibiting at next week’s Pharmapack Europe conference in Paris February 11-12. Pharmaceutical partners can learn more about the Companion Safety Syringe System and Innovation Without Change at Stand #728.

About Credence MedSystems, Inc.

Credence MedSystems is a medical technology and specialty pharmaceutical company focused on delivering medications safely for the benefit of our patients, caregivers and partners. The Credence Companion Safety Syringe System combines passive retractable needle safety with a modular approach that leaves the primary drug container unchanged, a major advantage for our pharmaceutical and biotechnology partners. Credence is also developing the expertise to provide our customers single-dose injectable medications in prefilled syringes.

Contacts

Credence MedSystems, Inc.
John A. Merhige, +1-844-263-3797 (844-CMEDSYS)
Chief Commercial Officer
jmerhige@credencemed.com
www.CredenceMed.com

Contacts

Credence MedSystems, Inc.
John A. Merhige, +1-844-263-3797 (844-CMEDSYS)
Chief Commercial Officer
jmerhige@credencemed.com
www.CredenceMed.com